News and press releases: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 July 2012
10:04 EDT 13 Jul 2012 | European Medicines Agency
The Committee adopted by consensus positive opinions for type II variation applications for: Suvaxyn PCV (porcine circovirus recombinant virus (cpcv) 1-2, inactivated) regarding manufacturing and quality of the product
Original Article: News and press releases: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 July 2012
More From BioPortfolio on "News and press releases: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 July 2012"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
